BRIEF published on 04/15/2025 at 10:05, 1 year 4 months ago Deutsche Rohstoff AG Considers Bond Expansion Amid High Demand Deutsche Rohstoff AG Oil Reserves Investor Demand Financial Flexibility Bond Expansion
BRIEF published on 04/15/2025 at 10:05, 1 year 4 months ago Deutsche Rohstoff AG envisage une expansion des obligations dans un contexte de forte demande Deutsche Rohstoff AG Demande Des Investisseurs Flexibilité Financière Réserves De Pétrole Expansion Des Obligations
BRIEF published on 04/15/2025 at 10:05, 1 year 4 months ago IOmx Therapeutics Gains Approval for IOMX-0675 Clinical Trials Immune Response IOmx Therapeutics IOMX-0675 Clinical Trial Approval Solid Tumor Therapy
BRIEF published on 04/15/2025 at 10:05, 1 year 4 months ago IOmx Therapeutics obtient l'approbation pour les essais cliniques sur IOMX-0675 Réponse Immunitaire IOmx Therapeutics IOMX-0675 Approbation Des Essais Cliniques Thérapie Des Tumeurs Solides
BRIEF published on 04/15/2025 at 10:04, 1 year 4 months ago NORMA Group Partners with Northern Gas Networks for Network Modernization Gas Distribution NORMA Group Electrofusion Fittings Northern Gas Networks Pipeline Modernization
BRIEF published on 04/15/2025 at 10:04, 1 year 4 months ago Le groupe NORMA s'associe à Northern Gas Networks pour la modernisation de son réseau Distribution De Gaz Groupe NORMA Raccords Électrosoudables Réseaux De Gaz Du Nord Modernisation Des Pipelines
BRIEF published on 04/15/2025 at 09:30, 1 year 4 months ago US Patent Notice for More Impact AG's Innovation Medical Innovation US Patent More Impact AG BG Braingate Technology CBD Extraction
BRIEF published on 04/15/2025 at 09:30, 1 year 4 months ago Avis de brevet américain concernant l'innovation de More Impact AG Innovation Médicale Brevet Américain Plus D'impact AG Technologie BG Braingate Extraction De CBD
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago LAIQON AG: Positive Growth and Financial Outlook for FY'25 Investment Recommendation Assets Under Management Financial Growth LAIQON AG Cost Management
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago LAIQON AG : Croissance positive et perspectives financières pour l'exercice 2025 Croissance Financière LAIQON AG Actifs Sous Gestion Gestion Des Coûts Recommandation D'investissement
Published on 09/11/2026 at 23:00, 26 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 hour 21 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 2 hours 1 minute ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 6 hours 26 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 6 hours 26 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 22:15, 1 hour 11 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 hour 15 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 3 hours 41 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 5 hours 10 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 16 hours 26 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 16 hours 26 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 16 hours 26 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 16 hours 26 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 3 hours ago Availability of the 2026 Interim Financial Report
